A new study published in Acta cardiologica on October 4, 2024, reviews the current evidence on sotatercept and provides a Belgian perspective on its place in the future treatment strategy for pulmonary arterial hypertension.
We are delighted to see that two patients from Belgium are included as co-authors. Wendy Vansteenkiste is the President of the Belgian pulmonary hypertension association PH Belgium – Pulmonale Hypertensie vzw and An Damen is Vice President. Their involvement which ensures that the patient perspective is represented, underscores the importance of integrating the patient voice in treatment strategy discussions.
Read more at this link on Acta Cardiologica
Citation
Vachiéry, J. L., Belge, C., Cools, B., Damen, A., Demeure, F., De Pauw, M., … Delcroix, M. (2024). A Belgian consensus on sotatercept for the treatment of pulmonary arterial hypertension. Acta Cardiologica, 1–6. https://doi.org/10.1080/00015385.2024.2408130